These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 18612045)

  • 1. The glucocorticoid receptor and FOXO1 synergistically activate the skeletal muscle atrophy-associated MuRF1 gene.
    Waddell DS; Baehr LM; van den Brandt J; Johnsen SA; Reichardt HM; Furlow JD; Bodine SC
    Am J Physiol Endocrinol Metab; 2008 Oct; 295(4):E785-97. PubMed ID: 18612045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cell-autonomous role for the glucocorticoid receptor in skeletal muscle atrophy induced by systemic glucocorticoid exposure.
    Watson ML; Baehr LM; Reichardt HM; Tuckermann JP; Bodine SC; Furlow JD
    Am J Physiol Endocrinol Metab; 2012 May; 302(10):E1210-20. PubMed ID: 22354783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sepsis increases the expression and activity of the transcription factor Forkhead Box O 1 (FOXO1) in skeletal muscle by a glucocorticoid-dependent mechanism.
    Smith IJ; Alamdari N; O'Neal P; Gonnella P; Aversa Z; Hasselgren PO
    Int J Biochem Cell Biol; 2010 May; 42(5):701-11. PubMed ID: 20079455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscle sparing in muscle RING finger 1 null mice: response to synthetic glucocorticoids.
    Baehr LM; Furlow JD; Bodine SC
    J Physiol; 2011 Oct; 589(Pt 19):4759-76. PubMed ID: 21807613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mountain ginseng inhibits skeletal muscle atrophy by decreasing muscle RING finger protein-1 and atrogin1 through forkhead box O3 in L6 myotubes.
    Seok YM; Yoo JM; Nam Y; Kim J; Kim JS; Son JH; Kim HJ
    J Ethnopharmacol; 2021 Apr; 270():113557. PubMed ID: 33161026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Excessive glucocorticoid-induced muscle MuRF1 overexpression is independent of Akt/FoXO1 pathway.
    Wang XJ; Xiao JJ; Liu L; Jiao HC; Lin H
    Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29046370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of atrogin-1 and MuRF1 prevents dexamethasone-induced atrophy of cultured myotubes.
    Castillero E; Alamdari N; Lecker SH; Hasselgren PO
    Metabolism; 2013 Oct; 62(10):1495-502. PubMed ID: 23866982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dependence of dexamethasone-induced Akt/FOXO1 signaling, upregulation of MAFbx, and protein catabolism upon the glucocorticoid receptor.
    Zhao W; Qin W; Pan J; Wu Y; Bauman WA; Cardozo C
    Biochem Biophys Res Commun; 2009 Jan; 378(3):668-72. PubMed ID: 19059383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of functional glucocorticoid response elements in the mouse FoxO1 promoter.
    Qin W; Pan J; Qin Y; Lee DN; Bauman WA; Cardozo C
    Biochem Biophys Res Commun; 2014 Jul; 450(2):979-83. PubMed ID: 24971545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muscle-specific microRNA1 (miR1) targets heat shock protein 70 (HSP70) during dexamethasone-mediated atrophy.
    Kukreti H; Amuthavalli K; Harikumar A; Sathiyamoorthy S; Feng PZ; Anantharaj R; Tan SL; Lokireddy S; Bonala S; Sriram S; McFarlane C; Kambadur R; Sharma M
    J Biol Chem; 2013 Mar; 288(9):6663-78. PubMed ID: 23297411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PPARβ/δ regulates glucocorticoid- and sepsis-induced FOXO1 activation and muscle wasting.
    Castillero E; Alamdari N; Aversa Z; Gurav A; Hasselgren PO
    PLoS One; 2013; 8(3):e59726. PubMed ID: 23555761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors.
    Stitt TN; Drujan D; Clarke BA; Panaro F; Timofeyva Y; Kline WO; Gonzalez M; Yancopoulos GD; Glass DJ
    Mol Cell; 2004 May; 14(3):395-403. PubMed ID: 15125842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SMAD3 augments FoxO3-induced MuRF-1 promoter activity in a DNA-binding-dependent manner.
    Bollinger LM; Witczak CA; Houmard JA; Brault JJ
    Am J Physiol Cell Physiol; 2014 Aug; 307(3):C278-87. PubMed ID: 24920680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcription factor FoxO1, the dominant mediator of muscle wasting in chronic kidney disease, is inhibited by microRNA-486.
    Xu J; Li R; Workeneh B; Dong Y; Wang X; Hu Z
    Kidney Int; 2012 Aug; 82(4):401-11. PubMed ID: 22475820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Forkhead box O3 plays a role in skeletal muscle atrophy through expression of E3 ubiquitin ligases MuRF-1 and atrogin-1 in Cushing's syndrome.
    Kang SH; Lee HA; Kim M; Lee E; Sohn UD; Kim I
    Am J Physiol Endocrinol Metab; 2017 Jun; 312(6):E495-E507. PubMed ID: 28246104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dexamethasone and corticosterone induce similar, but not identical, muscle wasting responses in cultured L6 and C2C12 myotubes.
    Menconi M; Gonnella P; Petkova V; Lecker S; Hasselgren PO
    J Cell Biochem; 2008 Oct; 105(2):353-64. PubMed ID: 18615595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IGF-I stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin ligases, atrogin-1 and MuRF1.
    Sacheck JM; Ohtsuka A; McLary SC; Goldberg AL
    Am J Physiol Endocrinol Metab; 2004 Oct; 287(4):E591-601. PubMed ID: 15100091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx/atrogin-1.
    Bodine SC; Baehr LM
    Am J Physiol Endocrinol Metab; 2014 Sep; 307(6):E469-84. PubMed ID: 25096180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ChIP-seq-defined networks of Bcl-3 gene binding support its required role in skeletal muscle atrophy.
    Jackman RW; Wu CL; Kandarian SC
    PLoS One; 2012; 7(12):e51478. PubMed ID: 23251550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NF-κB but not FoxO sites in the MuRF1 promoter are required for transcriptional activation in disuse muscle atrophy.
    Wu CL; Cornwell EW; Jackman RW; Kandarian SC
    Am J Physiol Cell Physiol; 2014 Apr; 306(8):C762-7. PubMed ID: 24553183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.